BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10666001)

  • 21. Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices.
    Siniscalchi A; Rodi D; Beani L; Bianchi C
    Br J Pharmacol; 1999 Sep; 128(1):119-23. PubMed ID: 10498842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal [Nphe1]nociceptin( 1-13)NH2 selectively reduces the spinal inhibitory effect of nociceptin.
    Xu IS; Grass S; Calo G; Guerrini R; Wiesenfeld-Hallin Z; Xu XJ
    Life Sci; 2002 Jan; 70(10):1151-7. PubMed ID: 11848299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of vestibular function by nociceptin/orphanin FQ: an in vivo and in vitro study.
    Sulaiman MR; Niklasson M; Tham R; Dutia MB
    Brain Res; 1999 May; 828(1-2):74-82. PubMed ID: 10320726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors.
    Schlicker E; Werthwein S; Kathmann M; Bauer U
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):418-22. PubMed ID: 9826063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats.
    Yu LC; Lu JT; Huang YH; Meuser T; Pietruck C; Gabriel A; Grond S; Pierce Palmer P
    Brain Res; 2002 Jul; 945(1):88-96. PubMed ID: 12113955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor.
    Hashimoto Y; Caló G; Guerrini R; Smith G; Lambert DG
    Neurosci Lett; 2000 Jan; 278(1-2):109-12. PubMed ID: 10643813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orphanin-FQ/nociceptin inhibits kindling epileptogenesis and enhances hippocampal feed-forward inhibition.
    Gutiérrez R; Leff P; Romo-Parra H; Acevedo R; Antón B
    Neuroscience; 2001; 105(2):325-33. PubMed ID: 11672600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist.
    Calo' G; Guerrini R; Bigoni R; Rizzi A; Bianchi C; Regoli D; Salvadori S
    J Med Chem; 1998 Aug; 41(18):3360-6. PubMed ID: 9719588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist.
    Polidori C; Calo G; Ciccocioppo R; Guerrini R; Regoli D; Massi M
    Psychopharmacology (Berl); 2000 Mar; 148(4):430-7. PubMed ID: 10928317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nociceptin, OP4 receptor ligand in different models of experimental epilepsy.
    Rubaj A; Zgodzinski W; Gustaw K; Sieklucka-Dziuba M
    Peptides; 2002 Mar; 23(3):497-505. PubMed ID: 11835999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of nociceptin in unanesthetized mice.
    Madeddu P; Salis MB; Milia AF; Emanueli C; Guerrini R; Regoli D; Calò G
    Hypertension; 1999 Mar; 33(3):914-9. PubMed ID: 10082508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors.
    Malinowska B; Piszcz J; Koneczny B; Hryniewicz A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):233-41. PubMed ID: 11521166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens.
    Bigoni R; Calo G; Guerrini R; Strupish JW; Rowbotham DJ; Lambert DG
    Br J Clin Pharmacol; 2001 Apr; 51(4):355-8. PubMed ID: 11318773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of [Nphe1]nociceptin(1-13)NH2, [Phe1(CH2-NH)Gly2]nociceptin(1- 13)NH2, and nocistatin on nociceptin inhibited constrictions of guinea pig isolated bronchus.
    Yang Q; Chen Y; Fu C; Chang M; Peng Y; Wang R
    Protein Pept Lett; 2006; 13(2):185-8. PubMed ID: 16472082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nociceptin attenuates opioid and gamma-aminobutyric acid(B) receptor-mediated analgesia in the mouse tail-flick assay.
    Citterio F; Corradini L; Smith RD; Bertorelli R
    Neurosci Lett; 2000 Oct; 292(2):83-6. PubMed ID: 10998554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat.
    Sandin J; Ogren SO; Terenius L
    Brain Res; 2004 Feb; 997(2):222-33. PubMed ID: 14706874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of intrathecally administered nociceptin on the expression of Fos-like immunoreactivity in the rat formalin test.
    Yamamoto T; Ohtori S; Chiba T
    Neurosci Lett; 2000 Apr; 284(3):155-8. PubMed ID: 10773422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade effects of (Nphe1)Nociceptin(1-13)-NH(2) on anti-nociception induced by intrathecal administration of nociceptin in rats.
    Lu JT; Huang YH; Palmer PP; Xie GX; Gabriel A; Grond S; Yu LC
    Regul Pept; 2001 Sep; 101(1-3):81-5. PubMed ID: 11495682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.